No abstract available
MeSH terms
-
Androgen Antagonists / pharmacology
-
Androgen Antagonists / therapeutic use*
-
Androstenes / pharmacology
-
Androstenes / therapeutic use
-
Antineoplastic Agents, Hormonal / pharmacology
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Docetaxel / pharmacology
-
Docetaxel / therapeutic use
-
Drug Resistance, Neoplasm
-
Humans
-
Male
-
Network Meta-Analysis
-
Progression-Free Survival
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / mortality
-
Randomized Controlled Trials as Topic
-
Survival Rate
-
Systematic Reviews as Topic
Substances
-
Androgen Antagonists
-
Androstenes
-
Antineoplastic Agents, Hormonal
-
Docetaxel
-
abiraterone